MedPath

?Exir research project of desferoxamin with brand name of Deferoxir

Not Applicable
Conditions
thalassemia major.
Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia major
Registration Number
IRCT2015012620818N1
Lead Sponsor
exir pharmacutical company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients with major thalassemia under regular blood injection therapy;. age over 5; undergoing treatment with one of deferoxamine pharmaceutical products; Norma renal function; serum cratinine undr 0. 7; in children under the age of 12 less than 1.0; in teenagers less than 1.1; and in over 16 years old pateinets (female less than 1.2; male less than 1.2); Trans aminase enzymes level less than 2 times of normal range; BUN<22mg/dl.

Exclusion Criteria

Any experience of allergic reaction to desferoxamine, positive HCV Ab / HBS Ag.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ferritin. Timepoint: every 2 month from begining of study. Method of measurement: blood test.;SGOT. Timepoint: every 2 month from begining of study. Method of measurement: blood test.;SGPT. Timepoint: every 2 month from begining of study. Method of measurement: blood test.;Cr. Timepoint: every 2 month from begining of study. Method of measurement: blood test.;WBC. Timepoint: every 2 weeks. Method of measurement: blood test.;Hgb. Timepoint: every 2 weeks from begining of study. Method of measurement: blood test.;Platlet. Timepoint: every 2 weeks from begining of study. Method of measurement: blood test.
Secondary Outcome Measures
NameTimeMethod
Optometry. Timepoint: before study,6 months after begining of study,12 months after beginig of study. Method of measurement: optometry.;T2*MRI. Timepoint: before study,6 months after begining of study,12 months after beginig of study. Method of measurement: blood test.;Audiology. Timepoint: before study,6 months after begining of study,12 months after beginig of study. Method of measurement: Audiology.;Sonography. Timepoint: before study,6 months after begining of study,12 months after beginig of study. Method of measurement: Sonography.
© Copyright 2025. All Rights Reserved by MedPath